This list is based on the watchlists of people on Stock Events who follow ZSQR. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Show more...
FAQ
What is Z Squared stock price today?▼
The current price of ZSQR is $14.03 USD — it has increased by +1.34% in the past 24 hours. Watch Z Squared stock price performance more closely on the chart.
What is Z Squared stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Z Squared stocks are traded under the ticker ZSQR.
When is the next Z Squared earnings date?▼
Z Squared is going to release the next earnings report on June 03, 2026.
How many employees does Z Squared have?▼
As of May 07, 2026, the company has 5 employees.
In which sector is Z Squared located?▼
Z Squared operates in the Health & Wellness sector.
When did Z Squared complete a stock split?▼
Z Squared has not had any recent stock splits.
Where is Z Squared headquartered?▼
Z Squared is headquartered in Wexford, United States.